Evaluation of cefotaxime and desacetylcefotaxime concentrations in cord blood after intrapartum prophylaxis with cefotaxime

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 6, 2009, Pages 2342-2345

  Lepercq, Jacques ^a,b   Treluyer, Jean Marc ^a,b   Auger, Christelle ^a   Raymond, Josette ^a,b   Rey, Elisabeth ^a,b   Schmitz, Thomas ^a,b   Jullien, Vincent ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Groupe Hospitalier Cochin Saint Vincent de Paul ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; DEACETYLCEFOTAXIME;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG BLOOD LEVEL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; HUMAN; INTRAPARTUM CARE; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NEWBORN SEPSIS; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STREPTOCOCCUS AGALACTIAE; UMBILICAL CORD BLOOD;

AMPICILLIN RESISTANCE; ANTI-BACTERIAL AGENTS; BACTEREMIA; CEFOTAXIME; ENTEROBACTERIACEAE INFECTIONS; FEMALE; FETAL BLOOD; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; PREGNANCY;

EID: 67049107890     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01429-08     Document Type: Article

References (25)

1. Agence Nationale d'Accréditation et d'Evaluation en Santé. 2003. Diagnostic et traitement curatif de l'infection bactérienne précoce du nouveau né. Agence Nationale d'Accréditation et d'Evaluation en Santé, Saint Denis, France.
2. Allegaert, K., L. Lewi, G. Naulaers, and L. Lagae. 2006. Levetiracetam pharmacokinetics in neonates at birth. Epilepsia 47:1068-1069. (Pubitemid 43801518)
3. Boyer-Mariotte, S., P. Duboc, S. Bonacorsi, J. F. Lemeland, E. Bingen, and D. Pinquier. 2008. CTX-M-15-producing Escherichia coli in fatal neonatal meningitis: failure of empirical chemotherapy. J. Antimicrob. Chemother. 62:1472-1474.
4. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Craig, W. A. 2002. Pharmacodynamics of antimicrobials: general concepts and applications, p. 991-1022. In C. Nightingale, T. Marakawa, and P. G. Ambrose (ed.), Antimicrobial pharmacodynamics in theory and clinical practice. Marcel Dekker, New York, NY.
6. De Leeuw, J. W., F. J. Roumen, P. X. Bouckaert, H. M. Cremers, and T. B. Vree. 1993. Achievement of therapeutic concentrations of cefuroxime in early preterm gestations with premature rupture of the membranes. Obstet. Gynecol. 81:255-260.
7. Fujimoto, S., and Y. Kanagawa. 1982. Studies on the transplacental passage of cefotaxime in late pregnancy. Jpn. J. Antibiot. 35:1849-1854.
8. Gouyon, J. B., A. Pechinot, C. Safran, P. Chretien, D. Sandre, and A. Kazmierczak. 1990. Pharmacokinetics of cefotaxime in preterm infants. Dev. Pharmacol. Ther. 14:29-34.
9. Holt, D. E., N. M. Fisk, J. A. Spencer, de J. Louvois, R. Hurley, and D. Harvey. 1993. Transplacental transfer of cefuroxime in uncomplicated pregnancies and those complicated by hydrops or changes in amniotic fluid volume. Arch. Dis. Child. 68:54-57.
10. Jones, B., K. Peake, A. J. Morris, L. M. McCowan, and M. R. Battin. 2004. Escherichia coli: a growing problem in early onset neonatal sepsis. Aust. N. Z. J. Obstet. Gynaecol. 44:558-561.
11. Jones, R. N. 1995. Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review. Diagn. Microbiol. Infect. Dis. 22:19-33.
12. Kenyon, S., M. Boulvain, and J. Neilson. 2004. Antibiotics for preterm rupture of the membranes: a systematic review. Obstet. Gynecol. 104(5 Pt 1):1051-1057.
13. Mercer, B. M., T. L. Carr, D. D. Beazley, D. T. Crouse, and B. M. Sibai. 1999. Antibiotic use in pregnancy and drug-resistant infant sepsis. Am. J. Obstet. Gynecol. 181:816-821.
14. Nix, D. E., and J. J. Schentag. 1995. Role of pharmacokinetics and pharmacodynamics in the design of dosage schedules for 12-h cefotaxime alone and in combination with other antibiotics. Diagn. Microbiol. Infect. Dis. 22:71-76.
15. Owens, R. C., Jr., and P. G. Ambrose. 2007. Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era. Diagn. Microbiol. Infect. Dis. 57(Suppl. 3):77S-83S.
16. Parry, S., and J. F. Strauss III. 1998. Premature rupture of the fetal membranes. N. Engl. J. Med. 338:663-670.
17. Raymond, J., E. Lopez, S. Bonacorsi, C. Poyart, G. Moriette, P. H. Jarreau, and E. Bingen. 2008. Evidence for transmission of Escherichia coli from mother to child in late-onset neonatal infection. Pediatr. Infect. Dis. J. 27:186-188.
18. Romero, R., N. Athayde, E. Maymon, P. Pacora, and R. Bahado-Singh. 1999. Premature rupture of the membranes, p. 1581-1625. In A. Reece and J. Hobbins (ed.), Medicine of the fetus and mother. Lippincott-Raven, Philadelphia, PA.
19. Schrag, S. J., S. Zywicki, M. M. Farley, A. L. Reingold, L. H. Harrison, L. B. Lefkowitz, J. L. Hadler, R. Danila, P. R. Cieslak, and A. Schuchat. 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342:15-20.
20. Schrag, S. J., J. L. Hadler, K. E. Arnold, P. Martell-Cleary, A. Reingold, and A. Schuchat. 2006. Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics 118:570-576. (Pubitemid 46085412)
21. Stoll, B. J., T. Gordon, S. B. Korones, S. Shankaran, J. E. Tyson, C. R. Bauer, A. A. Fanaroff, J. A. Lemons, E. F. Donovan, W. Oh, D. K. Stevenson, R. A. Ehrenkranz, L. A. Papile, J. Verter, and L. L. Wright. 1996. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J. Pediatr. 129:72-80. (Pubitemid 26277249)
22. Stoll, B. J., N. Hansen, A. A. Fanaroff, L. L. Wright, W. A. Carlo, R. A. Ehrenkranz, J. A. Lemons, E. F. Donovan, A. R. Stark, J. E. Tyson, W. Oh, C. R. Bauer, S. B. Korones, S. Shankaran, A. R. Laptook, D. K. Stevenson, L. A. Papile, and W. K. Poole. 2002. Changes in pathogens causing earlyonset sepsis in very-low-birth-weight infants. N. Engl. J. Med. 347:240-247.
23. Syme, M. R., J. W. Paxton, and J. A. Keelan. 2004. Drug transfer and metabolism by the human placenta. Clin. Pharmacokinet. 43:487-514.
24. Terrone, D. A., B. K. Rinehart, M. H. Einstein, L. B. Britt, J. N. Martin, Jr., and K. G. Perry. 1999. Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration. Am. J. Obstet. Gynecol. 180(6 Pt 1):1345-1348.
25. Towers, C. V., and G. G. Briggs. 2002. Antepartum use of antibiotics and early-onset neonatal sepsis: the next 4 years. Am. J. Obstet. Gynecol. 187:495-500.